Clinical trials
Suspended trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 8 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 72 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 9 |
| Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète | 4 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Centre Leon Berard | 2 |
| GCS CIPS | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| UNICANCER | 2 |
| University Hospital, Clermont-Ferrand | 2 |
| University Hospital, Limoges | 2 |
| University Hospital, Montpellier | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 2 |
| Amyotrophic Lateral Sclerosis | 2 |
| COVID-19 | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Major Depressive Disorder | 2 |
| Ovarian Neoplasms | 2 |
| Sepsis | 2 |
| Stroke | 2 |
Trials
Showing 76 to 72 of 72. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.